enterprise

NMTC Stock Earnings: NeuroOne Medical Tech Beats EPS, Misses Revenue for Q4 2023 – InvestorPlace


NMTC stock - NMTC Stock Earnings: NeuroOne Medical Tech Beats EPS, Misses Revenue for Q4 2023

Source: iQoncept / Shutterstock

NeuroOne Medical Tech (NASDAQ:NMTC) just reported results for the fourth quarter of 2023.

  • NeuroOne Medical Tech reported earnings per share of -13 cents. This was above the analyst estimate for EPS of -17 cents.
  • The company reported revenue of $741,780.
  • This was 7.28% worse than the analyst estimate for revenue of $800,000.

InvestorPlace Earnings is a project that leverages data from TradeSmith to automate coverage of quarterly earnings reports. InvestorPlace Earnings distills key takeaways including earnings per share and revenue, as well as how a company stacks up to analyst estimates. These articles are published without human intervention, allowing us to inform our readers of the latest figures as quickly as possible. To report any concerns or inaccuracies, please contact us at editor@investorplace.com.


Article printed from InvestorPlace Media, https://investorplace.com/earning-results/2023/12/nmtc-stock-earnings-neuroone-medical-tech-for-q4-of-2023/.

©2023 InvestorPlace Media, LLC



READ SOURCE

Readers Also Like:  Research Analysts Issue Forecasts for Watts Water Technologies ... - MarketBeat

This website uses cookies. By continuing to use this site, you accept our use of cookies.